Retraction
EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma
Paper Information
Record ID:
42564
Journal:
Publication Date:
February 19, 2004
Retraction Date:
February 09, 2023
(2.8 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1038/s41388-023-02626-5Additional Notes:
see also: https://pubpeer.com/publications/5CD3A5CF37F120E2AE5390B007E2C8
Citations (219)
219
Total Citations9
Post-Retraction(4.1%)
208
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
7
Within 1 year
0
After 2+ years
475
Days since retraction (latest)
Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate
Ahmed F. Salem, Si Wang, Sandrine Billet et al. (11 authors)
Journal of Medicinal Chemistry
Open Access
Published: Feb 2018
63 citations
63 citations
1813 days before retraction
Nanogels as Targeted Drug Delivery Vehicles
Khushwant S. Yadav, Rajiv K. Saxena, Govind Soni
The Royal Society of Chemistry eBooks
Published: Nov 2017
5 citations
5 citations
1907 days before retraction
Mek activity is required for ErbB2 expression in breast cancer cells detached from the extracellular matrix
Iman Aftab Khan, Byong Hoon Yoo, Janusz Rak et al. (4 authors)
Oncotarget
Open Access
Published: Oct 2017
3 citations
3 citations
1927 days before retraction
Effect of dasatinib in a xenograft mouse model of canine histiocytic sarcoma and in vitro expression status of its potential target <scp>EPHA</scp>2
Keita Ito, Ryo Miyamoto, Hiroyuki Tani et al. (7 authors)
Journal of Veterinary Pharmacology and Therapeutics
Published: Aug 2017
5 citations
5 citations
2002 days before retraction
A Modified Adenovirus Vector–Mediated Antibody Screening Method Identifies EphA2 as a Cancer Target
Toshihiro Tanaka, Hiromi Yamada, Masahide Kuroki et al. (6 authors)
Translational Oncology
Open Access
Published: May 2017
7 citations
7 citations
2099 days before retraction
Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin
Daniel Delgado‐Bellido, Santiago Serrano, Mónica Fernández‐Cortés et al. (4 authors)
Molecular Cancer
Open Access
Published: Mar 2017
192 citations
192 citations
2151 days before retraction
Nanoplasmonic quantification of tumour-derived extracellular vesicles in plasma microsamples for diagnosis and treatment monitoring
Kai Liang, Fei Liu, Jia Fan et al. (13 authors)
Nature Biomedical Engineering
Open Access
Published: Feb 2017
334 citations
334 citations
2194 days before retraction
Hybrid nanoparticles coated with hyaluronic acid lipoid for targeted co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells
Zhe Yang, Na Sun, Rui Cheng et al. (6 authors)
Journal of Materials Chemistry B
Published: Jan 2017
84 citations
84 citations
2230 days before retraction
Communication of Drug Loaded Nanogels with Cancer Cell Receptors for Targeted Delivery
Govind Soni, Khushwant S. Yadav
Modeling and optimization in science and technologies
Published: Jan 2017
16 citations
16 citations
2230 days before retraction
Identification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile data
Ying Liu, Ran Ni, Hui Zhang et al. (7 authors)
OncoTargets and Therapy
Open Access
Published: Dec 2016
19 citations
19 citations
2261 days before retraction
EphA2 is a functional receptor for the growth factor progranulin
Thomas Neill, Simone Buraschi, Atul Kumar Goyal et al. (8 authors)
The Journal of Cell Biology
Open Access
Published: Nov 2016
120 citations
120 citations
2262 days before retraction
ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells
Iman Aftab Khan, Byounghyun Yoo, Olivier Masson et al. (8 authors)
Oncogene
Open Access
Published: Apr 2016
24 citations
24 citations
2481 days before retraction
Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with <sup>89</sup>Zr-DS-8895a
Ingrid J.G. Burvenich, Sagun Parakh, Hui Gan et al. (14 authors)
Journal of Nuclear Medicine
Open Access
Published: Mar 2016
27 citations
27 citations
2534 days before retraction
EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells
Min Cho, Sung Yong Cho, Cheol Yong Yoon et al. (7 authors)
PLoS ONE
Open Access
Published: Jul 2015
8 citations
8 citations
2766 days before retraction
Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells
Bainan Wu, Si Wang, Surya K. De et al. (11 authors)
Chemistry & Biology
Open Access
Published: Jul 2015
36 citations
36 citations
2780 days before retraction
Upregulation of ATG3 contributes to autophagy induced by the detachment of intestinal epithelial cells from the extracellular matrix, but promotes autophagy-independent apoptosis of the attached cells
Byong Hoon Yoo, Anna Zagryazhskaya, Yongling Li et al. (8 authors)
Autophagy
Open Access
Published: Jun 2015
24 citations
24 citations
2801 days before retraction
Dual targeting for metastatic breast cancer and tumor neovasculature by EphA2-mediated nanocarriers
Zhaoming Guo, Bing He, Lan Yuan et al. (9 authors)
International Journal of Pharmaceutics
Published: May 2015
31 citations
31 citations
2821 days before retraction
Targeting the EPHA2 receptor tyrosine kinase in KRAS and EGFR mutant lung cancer
Katherine Amato
Unknown Journal
Published: Mar 2015
2879 days before retraction
Role of the Family of Ephs and Ephrins in Cell-Cell Communication in Cancer
Mohamed Amessou, Mustapha Kandouz
Springer eBooks
Published: Jan 2015
2961 days before retraction
Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists
Byounghyun Yoo, Olivier Masson, Yu Li et al. (6 authors)
Oncogene
Open Access
Published: Dec 2014
10 citations
10 citations
2971 days before retraction
Ephs and Ephrins in malignant gliomas
Sara Ferluga, Waldemar Debinski
Growth Factors
Open Access
Published: Nov 2014
27 citations
27 citations
2999 days before retraction
Ephrin type-A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3-kinase/Akt signalling pathway
Yunyun Wang, Yong Liu, Guo Li et al. (9 authors)
Molecular Medicine Reports
Open Access
Published: Oct 2014
14 citations
14 citations
3025 days before retraction
EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice
Augustin DuSablon, Susan D. Kent, Anita Coburn et al. (4 authors)
Cardiovascular Diabetology
Open Access
Published: Aug 2014
15 citations
15 citations
3103 days before retraction
RNA Interference: a Promising Therapy for Gastric Cancer
Aledson Vitor Felipe, Juliana de Oliveira, Paula Yun Joo Chang et al. (7 authors)
Asian Pacific Journal of Cancer Prevention
Open Access
Published: Jul 2014
12 citations
12 citations
3116 days before retraction
Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers
Kazuya Nagano, Yuka Maeda, S. Kanasaki et al. (13 authors)
Journal of Controlled Release
Published: Jun 2014
45 citations
45 citations
3160 days before retraction
Overexpression of Ephrin A2 receptors in cancer stromal cells is a prognostic factor for the relapse of gastric cancer
Shojiro Kikuchi, Nobuaki Kaibe, Koji Morimoto et al. (12 authors)
Gastric Cancer
Open Access
Published: Jun 2014
24 citations
24 citations
3168 days before retraction
EphA receptors regulate prostate cancer cell dissemination through Vav2–RhoA mediated cell–cell repulsion
Jennifer Batson, Lucy MacCarthy‐Morrogh, Amy Archer et al. (5 authors)
Biology Open
Open Access
Published: May 2014
43 citations
43 citations
3205 days before retraction
Glioma stem cells: turpis omen in nomen? (the evil in the name?)
Elena Binda, Brent A. Reynolds, Angelo L. Vescovi
Journal of Internal Medicine
Open Access
Published: Apr 2014
25 citations
25 citations
3230 days before retraction
Design, Synthesis and Bioevaluation of an EphA2 Receptor‐Based Targeted Delivery System
Elisa Barile, Si Wang, Swadesh K. Das et al. (9 authors)
ChemMedChem
Open Access
Published: Mar 2014
34 citations
34 citations
3242 days before retraction
miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression
Xuanyu Chen, Xuegang Wang, Anming Ruan et al. (14 authors)
Clinical Cancer Research
Open Access
Published: Mar 2014
141 citations
141 citations
3248 days before retraction
Hydrogel-nanoparticle composites for optically modulated cancer therapeutic delivery
Laura E. Strong, Shreyas N. Dahotre, Jennifer L. West
Journal of Controlled Release
Open Access
Published: Jan 2014
84 citations
84 citations
3304 days before retraction
Современные молекулярные подходы к диагностике и лечению низкодифференцированных глиом
Г. В. Павлова, Владимир П. Баклаушев, М. А. Иванова et al. (12 authors)
Unknown Journal
Published: Jan 2014
3326 days before retraction
Modern molecular approaches to diagnosis and treatment of high-grade brain gliomas
Г. В. Павлова, Владимир П. Баклаушев, М. А. Иванова et al. (9 authors)
Burdenko s Journal of Neurosurgery
Published: Jan 2014
1 citation
1 citation
3326 days before retraction
Expression of Eph receptor A10 is correlated with lymph node metastasis and stage progression in breast cancer patients
Kazuya Nagano, S. Kanasaki, Takuya Yamashita et al. (12 authors)
Cancer Medicine
Open Access
Published: Nov 2013
36 citations
36 citations
3381 days before retraction
The diversity between pancreatic head and body/tail cancers: clinical parameters and in vitro models
Qi Ling, Xiao Xu, Shusen Zheng et al. (4 authors)
Hepatobiliary & pancreatic diseases international
Published: Oct 2013
51 citations
51 citations
3418 days before retraction
<i>IN VIVO</i> IMAGING AND DELIVERY OF siRNA
Zdravka Medarova, Anna Moore
Unknown Journal
Published: Sep 2013
1 citation
1 citation
3429 days before retraction
Human Pancreatic Cancer Contains a Side Population Expressing Cancer Stem Cell-Associated and Prognostic Genes
Anke Van den broeck, Hugo Vankelecom, Wouter Van Delm et al. (9 authors)
PLoS ONE
Open Access
Published: Sep 2013
70 citations
70 citations
3432 days before retraction
Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment
Masato Nishimura, Eun-Jung Jung, Maitri Shah et al. (23 authors)
Cancer Discovery
Open Access
Published: Sep 2013
152 citations
152 citations
3445 days before retraction
Simultaneous Profiling of 194 Distinct Receptor Transcripts in Human Cells
Byong H. Kang, Karin Jensen, Jaime A. Hatch et al. (4 authors)
Science Signaling
Open Access
Published: Aug 2013
31 citations
31 citations
3474 days before retraction
Overexpression of EPH Receptor B2 in Malignant Mesothelioma Correlates with Oncogenic Behavior
Chandra Goparaju, Jessica Donington, Tsungda Hsu et al. (6 authors)
Journal of Thoracic Oncology
Open Access
Published: Jul 2013
22 citations
22 citations
3486 days before retraction
EphA4 is a prognostic factor in gastric cancer
Kohji Miyazaki, Mikito Inokuchi, Yoko Takagi et al. (6 authors)
BMC Clinical Pathology
Open Access
Published: Jun 2013
47 citations
47 citations
3536 days before retraction
Nanoscale Obstacle Arrays Frustrate Transport of EphA2–Ephrin-A1 Clusters in Cancer Cell Lines
Theobald Lohmüller, Qian Xu, Jay T. Groves
Nano Letters
Open Access
Published: May 2013
34 citations
34 citations
3559 days before retraction
RNAi in Clinical Studies
P. Kubowicz, Dorota Żelaszczyk, Elżbieta Pękala
Current Medicinal Chemistry
Open Access
Published: Mar 2013
63 citations
63 citations
3632 days before retraction
Differential effects of low‐ and high‐dose GW2974, a dual epidermal growth factor receptor and HER2 kinase inhibitor, on glioblastoma multiforme invasion
Lulu Wang, Qian Liu, Hong Zhao et al. (9 authors)
Journal of Neuroscience Research
Published: Nov 2012
10 citations
10 citations
3752 days before retraction
Phosphatase and tensin homolog regulates stability and activity of EphB1 receptor
Stéphane Rodriguez, Uyen Huynh‐Do
The FASEB Journal
Published: Nov 2012
6 citations
6 citations
3752 days before retraction
Ephs and ephrins resurface in inflammation, immunity, and atherosclerosis
Steven D. Funk, A. Wayne Orr
Pharmacological Research
Published: Oct 2012
78 citations
78 citations
3761 days before retraction
Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells
Thomas Tawadros, M.D. Brown, Claire A. Hart et al. (4 authors)
British Journal of Cancer
Open Access
Published: Oct 2012
37 citations
37 citations
3780 days before retraction
Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner
Amar B. Singh, Ashok Sharma, Punita Dhawan
Carcinogenesis
Open Access
Published: Sep 2012
75 citations
75 citations
3813 days before retraction
RETRACTED ARTICLE: Signaling pathways in tumor vasculogenic mimicry
А. А. Вартанян
Biochemistry (Moscow)
Published: Sep 2012
23 citations
23 citations
3813 days before retraction
Molecular markers associated with outcome and metastasis in human pancreatic cancer
Anke Van den broeck, Hugo Vankelecom, Rudy van Eijsden et al. (5 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Aug 2012
81 citations
81 citations
3818 days before retraction
Quick Stats
Total Citations:
219
Years Since Retraction:
2.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025